2 months ago
IBRX
AnalystsAndres Y. MaldonadoAndres Y. Maldonado's Stock Forecasts
AnalystsAndres Y. Maldonado
Sectors:
Industries:
Analyst Ranking
Top 6%
#291 out of 5266 analysts
Average Return
+41.99%
Win Rate
67%35 out of 52
Risk vs Reward
Poor
Good
Andres Y. Maldonado's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunitybio IncIBRX | +213.71% | $2.48 | $7.78 | 2025-04-15 - 2026-04-15 | Buy |
Terns Pharmaceuticals IncTERN | +203.27% | $17.43 | $52.86 | 2025-11-03 - 2026-03-25 | Buy |
Immunitybio IncIBRX | +201.27% | $2.36 | $7.11 | 2025-05-11 - 2026-05-01 | Buy |
Immunitybio IncIBRX | +199.67% | $2.99 | $8.96 | 2025-03-05 - 2026-03-05 | Buy |
Immunitybio IncIBRX | +177.19% | $2.63 | $7.29 | 2025-04-27 - 2026-04-27 | Buy |
Andres Y. Maldonado Analyst Color
Get additional color on Andres Y. Maldonado's coverage of popular stocks
Andres Y. Maldonado's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Verastem IncVSTM | 2 | Buy | $18.00 | +208.22% | Reiterates | 23 days ago |
Novabridge BiosciencesNBP | 4 | Buy | $9.00 | +278.15% | Reiterates | 25 days ago |
Cg Oncology IncCGON | 6 | Buy | $100.00 | +50.90% | Maintains | a month ago |
Aura Biosciences IncAURA | 2 | Buy | $22.00 | +213.84% | Reiterates | a month ago |
Terns Pharmaceuticals IncTERN | 3 | Hold | $53.00 | +0.13% | Downgrades | a month ago |
Sutro Biopharma IncSTRO | 2 | Buy | $28.00 | -21.33% | Upgrades | a month ago |
Erasca IncERAS | 3 | Buy | $20.00 | +99.40% | Maintains | 2 months ago |
Foghorn Therapeutics IncFHTX | 1 | Buy | $13.00 | +173.11% | Reiterates | 2 months ago |
Day One Biopharmaceuticals IncDAWN | 3 | Hold | $21.50 | -0.14% | Downgrades | 2 months ago |
Engene Therapeutics IncENGN | 3 | Buy | $25.00 | +244.83% | Reiterates | 2 months ago |
Scholar Rock Holding CorpSRRK | 3 | Buy | $58.00 | +25.08% | Reiterates | 2 months ago |
Immunitybio IncIBRX | 9 | Buy | $15.00 | +110.97% | Maintains | 2 months ago |
Immunome IncIMNM | 1 | Buy | $40.00 | +75.98% | Initiates Coverage On | 3 months ago |
Protara Therapeutics IncTARA | 3 | Buy | $23.00 | +332.33% | Reiterates | 3 months ago |
Werewolf Therapeutics IncHOWL | 1 | Buy | $4.00 | +453.25% | Maintains | 4 months ago |
Tscan Therapeutics IncTCRX | 1 | Buy | $7.00 | +473.77% | Maintains | 6 months ago |
Syndax Pharmaceuticals IncSNDX | 2 | Buy | $40.00 | +109.31% | Reiterates | 6 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 2 | Buy | $40.00 | +288.35% | Reiterates | 6 months ago |
Merus NvMRUS | 1 | Hold | $97.00 | +7.78% | Downgrades | 7 months ago |
Candel Therapeutics IncCADL | 1 | Buy | $23.00 | +255.49% | Reiterates | 7 months ago |
Monopar TherapeuticsMNPR | 2 | Buy | $105.00 | +97.18% | Maintains | 7 months ago |
Keros Therapeutics IncKROS | 1 | Buy | $20.00 | +74.06% | Maintains | 9 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.